0001437749-23-003836.txt : 20230217
0001437749-23-003836.hdr.sgml : 20230217
20230217173055
ACCESSION NUMBER: 0001437749-23-003836
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230215
FILED AS OF DATE: 20230217
DATE AS OF CHANGE: 20230217
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jones Andrew D.
CENTRAL INDEX KEY: 0001811872
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33678
FILM NUMBER: 23644212
MAIL ADDRESS:
STREET 1: 2000 POWELL STREET
STREET 2: SUITE 1150
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NovaBay Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001389545
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 680454536
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2000 POWELL STREET, SUITE 1150
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: (510) 899-8800
MAIL ADDRESS:
STREET 1: 2000 POWELL STREET, SUITE 1150
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
4
1
rdgdoc.xml
FORM 4
X0306
4
2023-02-15
1
0001389545
NovaBay Pharmaceuticals, Inc.
NBY
0001811872
Jones Andrew D.
C/O NOVABAY PHARMACEUTICALS, INC.
2000 POWELL STREET, SUITE 1150
EMERYVILLE
CA
94608
1
CFO
The reporting person departed from his position at NovaBay Pharmaceuticals, Inc., effective February 15, 2023. As a result, the reporting person is no longer subject to Section 16 in connection with his transactions in the equity securities of NovaBay Pharmaceuticals, Inc. and therefore will no longer report any such transactions on Form 4 or Form 5.
/s/ Andrew D. Jones
2023-02-17